Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Fos proto-oncogene, AP-1 transcription factor subunit | 0.411 | 0.885 | 0.26 |
|
phenotype | 0.300 | None | 1.000 | 4 | 0 | 1994 | 2008 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
phenotype | 0.300 | None | 1.000 | 4 | 0 | 2004 | 2008 | ||||||||
|
glutamate metabotropic receptor 1 | 0.528 | 0.808 | 0.14 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2004 | 2007 | ||||||||
|
glutamate metabotropic receptor 5 | 0.525 | 0.846 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2007 | 2008 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2009 | 2009 | ||||||||
|
glial cell derived neurotrophic factor | 0.434 | 0.885 | 0.20 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 1994 | 2003 | ||||||||
|
C-C motif chemokine receptor 2 | 0.418 | 0.846 | 2.3E-02 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2009 | 2009 | ||||||||
|
erythropoietin | 0.381 | 0.885 | 1.1E-02 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2006 | 2007 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 1996 | 1996 | ||||||||
|
nerve growth factor | 0.391 | 0.885 | 0.82 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 1996 | 1996 | ||||||||
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2006 | 2008 | ||||||||
|
neurotrophic receptor tyrosine kinase 2 | 0.479 | 0.808 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 1996 | 1996 | ||||||||
|
syntrophin alpha 1 | 0.678 | 0.308 | 5.6E-03 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
solute carrier family 8 member A3 | 0.666 | 0.346 | 7.3E-04 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
solute carrier family 8 member A1 | 0.544 | 0.769 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
C-C motif chemokine ligand 3 | 0.460 | 0.885 | 0.35 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
eukaryotic translation initiation factor 2 alpha kinase 2 | 0.538 | 0.769 | 1.8E-02 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
sodium voltage-gated channel alpha subunit 8 | 0.510 | 0.731 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
solute carrier family 12 member 5 | 0.570 | 0.654 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
SRC proto-oncogene, non-receptor tyrosine kinase | 0.467 | 0.885 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
somatostatin receptor 1 | 0.606 | 0.615 | 0.75 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
eukaryotic translation initiation factor 2 alpha kinase 3 | 0.501 | 0.808 | 2.8E-03 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
beclin 1 | 0.432 | 0.846 | 0.94 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 |